Free Trial
NASDAQ:SCLX

Scilex (SCLX) Stock Price, News & Analysis

Scilex logo
$15.78 -1.57 (-9.05%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$15.82 +0.04 (+0.22%)
As of 10/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Scilex Stock (NASDAQ:SCLX)

Advanced

Key Stats

Today's Range
$14.80
$17.58
50-Day Range
$12.94
$30.00
52-Week Range
$3.60
$39.90
Volume
507,226 shs
Average Volume
294,576 shs
Market Capitalization
$109.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$455.00
Consensus Rating
Hold

Company Overview

Scilex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

SCLX MarketRank™: 

Scilex scored higher than 48% of companies evaluated by MarketBeat, and ranked 604th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Scilex has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Scilex has a consensus price target of $455.00, representing about 2,783.4% upside from its current price of $15.78.

  • Amount of Analyst Coverage

    Scilex has only been the subject of 1 research reports in the past 90 days.

  • Read more about Scilex's stock forecast and price target.
  • Earnings Growth

    Earnings for Scilex are expected to grow in the coming year, from ($0.57) to ($0.41) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Scilex is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Scilex is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Scilex's valuation and earnings.
  • Percentage of Shares Shorted

    10.32% of the float of Scilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Scilex has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Scilex has recently increased by 5.72%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Scilex does not currently pay a dividend.

  • Dividend Growth

    Scilex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.32% of the float of Scilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Scilex has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Scilex has recently increased by 5.72%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Scilex has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Scilex this week, compared to 2 articles on an average week.
  • Search Interest

    Only 14 people have searched for SCLX on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
  • MarketBeat Follows

    21 people have added Scilex to their MarketBeat watchlist in the last 30 days. This is an increase of 425% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Scilex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.94% of the stock of Scilex is held by insiders.

  • Percentage Held by Institutions

    69.67% of the stock of Scilex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Scilex's insider trading history.
Receive SCLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCLX Stock News Headlines

Digital data flow on road in concept of cyber global communication and coding — Photo
Datavault AI: The New AI Contender Backed by Big Funding (SCLX)
Datavault AI's recent nine-figure investment and a partnership with IBM signal a fundamental inflection point for this emerging AI growth company.
URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
See More Headlines

SCLX Stock Analysis - Frequently Asked Questions

Scilex's stock was trading at $14.9240 at the start of the year. Since then, SCLX shares have increased by 5.7% and is now trading at $15.78.

Scilex Holding Company (NASDAQ:SCLX) posted its quarterly earnings data on Wednesday, August, 13th. The company reported ($7.42) EPS for the quarter, missing the consensus estimate of ($4.55) by $2.87. The company had revenue of $9.90 million for the quarter, compared to analyst estimates of $26.25 million.

Shares of Scilex reverse split on Tuesday, April 15th 2025.The 1-35 reverse split was announced on Friday, April 11th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of SCLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scilex investors own include Rigetti Computing (RGTI), Pfizer (PFE), BioNTech (BNTX), Hertz Global (HTZ), BlackBerry (BB).

Company Calendar

Last Earnings
8/13/2025
Today
10/05/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCLX
CIK
1820190
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$630.00
Low Price Target
$245.00
Potential Upside/Downside
+2,783.4%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($29.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.81 million
Net Margins
-179.12%
Pretax Margin
-183.01%
Return on Equity
N/A
Return on Assets
-109.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.11
Quick Ratio
0.10

Sales & Book Value

Annual Sales
$56.59 million
Price / Sales
1.94
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($27.68) per share
Price / Book
-0.57

Miscellaneous

Outstanding Shares
6,960,000
Free Float
6,404,000
Market Cap
$109.83 million
Optionable
No Data
Beta
1.36
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SCLX) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners